Zelluna Immunotherapy
Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.
Zelluna Immunotherapy has raised €7.5M across 2 funding rounds from 1 investor, most recently a round in Aug 2022. Based in Oslo, Norway; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€7.5M
€7,500,000
Funding rounds
2
Investors
1
distinct backers
Active since
2020-12
latest 2022-08
Funding by year
EUR raised per yearZelluna Immunotherapy — funding by year — interactive chart.
Data table
| Zelluna Immunotherapy — funding by year | |
|---|---|
| 2020 | €7.5M |
| 2022 | €0 |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-25 | Other | — | Takeda Ventures | View deal → |
| 2020-12-06 | Other | €7.5M | — | View deal → |
Investors
1Related news
- Zelluna Immunotherapy Receives Investment from Takeda Venturesfinsmes.com · 2022-08
- finsmes.com
Similar companies
same sector or country- Visma€3.0BNorway · Software
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Adevinta€1.9BNorway · Marketing
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData